Search research articles
Contact Us
Filters
Showing results (11-20 of 91) with videos related to
Page
of 10
Sort By:
Clinical Pharmacokinetics
|
August 1, 1997
Clinical pharmacokinetics and pharmacodynamics of selegiline. An update
I Mahmood
Journal of Pharmaceutical Sciences
|
November 17, 1999
Allometric issues in drug development
I Mahmood
The Journal of Pharmacy and Pharmacology
|
September 30, 1999
Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study
I Mahmood
Drug Metabolism and Drug Interactions
|
August 30, 2000
Can absolute oral bioavailability in humans be predicted from animals? A comparison of allometry and different indirect methods
I Mahmood
American Journal of Therapeutics
|
April 17, 2001
Interspecies scaling of maximum tolerated dose of anticancer drugs: relevance to starting dose for phase I clinical trials
I Mahmood
Drug Metabolism and Drug Interactions
|
July 20, 2001
Interspecies scaling: is a priori knowledge of cytochrome p450 isozymes involved in drug metabolism helpful in prediction of clearance in humans from animal data?
I Mahmood
American Journal of Therapeutics
|
March 31, 1999
Simple method for the estimation of absorption rate constant(ka) after oral administration
I Mahmood
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 16, 2009
Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators
I Mahmood
Journal of Clinical Pharmacology
|
April 13, 2000
Critique of prospective allometric scaling: does the emperor have clothes?
I Mahmood
Journal of Pharmaceutical Sciences
|
May 1, 1997
A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics
I Mahmood
Page
of 10
Search research articles
Search
Showing results (11-20 of 91) with videos related to
Sort By:
Page
of 10
Clinical Pharmacokinetics
|
August 1, 1997
Clinical pharmacokinetics and pharmacodynamics of selegiline. An update
I Mahmood
Journal of Pharmaceutical Sciences
|
November 17, 1999
Allometric issues in drug development
I Mahmood
The Journal of Pharmacy and Pharmacology
|
September 30, 1999
Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study
I Mahmood
Drug Metabolism and Drug Interactions
|
August 30, 2000
Can absolute oral bioavailability in humans be predicted from animals? A comparison of allometry and different indirect methods
I Mahmood
American Journal of Therapeutics
|
April 17, 2001
Interspecies scaling of maximum tolerated dose of anticancer drugs: relevance to starting dose for phase I clinical trials
I Mahmood
Drug Metabolism and Drug Interactions
|
July 20, 2001
Interspecies scaling: is a priori knowledge of cytochrome p450 isozymes involved in drug metabolism helpful in prediction of clearance in humans from animal data?
I Mahmood
American Journal of Therapeutics
|
March 31, 1999
Simple method for the estimation of absorption rate constant(ka) after oral administration
I Mahmood
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 16, 2009
Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators
I Mahmood
Journal of Clinical Pharmacology
|
April 13, 2000
Critique of prospective allometric scaling: does the emperor have clothes?
I Mahmood
Journal of Pharmaceutical Sciences
|
May 1, 1997
A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics
I Mahmood
Page
of 10